134,900.000
0.000 BRL
−2.68 B BRL
6.21 B BRL
About Sarepta Therapeutics, Inc.
Sector
CEO
Douglas S. Ingram
Headquarters
Cambridge
Website
Founded
1980
ISIN
BRS1RPBDR005
FIGI
BBG00XV42L87
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027Yield to maturity
−2.91%
Maturity date
Sep 15, 2027
Explore more bonds
Curated watchlists where S1RP34 is featured.